Atrium Therapeutics, Inc. (RNA)
10.36
-0.15
(-1.43%)
USD |
NASDAQ |
Sep 10, 16:00
10.36
0.00 (0.00%)
After-Hours: 19:17
Atrium Therapeutics EPS Diluted (Quarterly) : -1.18 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.18 |
| March 31, 2026 | -0.9724 |
| December 31, 2025 | -1.702 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.7529 |
| March 31, 2025 | -0.4355 |
| December 31, 2024 | -0.6726 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -0.35 |
| Exicure, Inc. | -0.1759 |
| Century Therapeutics, Inc. | -0.1679 |
| Absci Corp. | -0.2109 |
| Celularity, Inc. | -0.8477 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.19M |
| Revenue (Quarterly) | 3.004M |
| Total Expenses (Quarterly) | 23.19M |
| Enterprise Value | -82.74M |
| Gross Profit Margin (Quarterly) | 88.58% |
| Profit Margin (Quarterly) | -672.0% |
| Earnings Yield | -44.48% |
| Normalized Earnings Yield | -44.48 |